Evidence map›Paper›PMID 42646774›Full record

ArticleToxins2026

Ochratoxin A Toxicity Research in In Vitro and In Vivo Experimental Settings: A Cross-Software Bibliometric and Science-Mapping Study.

José Manuel Veiga-Del-Baño, José Oliva, Pedro Andreo-Martínez, Miguel Motas, Eva María Mateo, José Miguel Soria, María Ángeles García-Esparza

Abstract read
In one paragraph

Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

José Manuel Veiga-Del-BañoDepartment of Agricultural Chemistry, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, Campus of Espinardo, 30100 Murcia, Spain.ORCID 0000-0002-2463-7706
José OlivaDepartment of Agricultural Chemistry, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, Campus of Espinardo, 30100 Murcia, Spain.
Pedro Andreo-MartínezDepartment of Agricultural Chemistry, Faculty of Chemistry, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, Campus of Espinardo, 30100 Murcia, Spain.ORCID 0000-0001-6535-5492
Miguel MotasDepartment of Toxicology, Faculty of Veterinary, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, Campus of Espinardo, 30100 Murcia, Spain.ORCID 0000-0002-2229-7779
Eva María MateoDepartment of Microbiology and Ecology, Faculty of Medicine and Odontology, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0001-7841-9838
José Miguel SoriaDepartment of Biomedical Sciences, Universidad Cardenal Herrera-CEU, CEU Universities, 03204 Elche, Spain.ORCID 0000-0001-9144-5096
María Ángeles García-EsparzaDepartment of Pharmacy, Universidad Cardenal Herrera-CEU, CEU Universities, 03204 Elche, Spain.ORCID 0000-0001-6510-0879

Funding

Programa de Investigación a Grupos de Investigación Reconocidos (GIR) GIR25/18 and GIR25/61
6 · The paper itself

Abstract

backgroundOchratoxin A (OTA) is a widespread mycotoxin with well-established nephrotoxic, immunotoxic, and carcinogenic properties. Despite decades of research, the structure, thematic evolution, and emerging directions of the scientific literature on OTA toxicity remain incompletely mapped.

methodsA bibliometric analysis was conducted using 883 publications indexed in the Web of Science Core Collection (1965-2025). Bibliometrix, VOSviewer, and BibExcel were integrated within a comparative cross-software workflow to assess publication trends, collaboration networks, thematic evolution, and thematic research directions in in vitro and in vivo OTA toxicity studies, while enabling cross-validation of the main bibliometric outputs.

resultsAfter normalisation, authors, journals, author keywords, and Keywords Plus showed strong cross-software agreement, whereas country and institution outputs retained software dependent differences related mainly to country aggregation and affiliation parsing. Publication output increased substantially over the analysed period, particularly during the most recent decade, reflecting the growing visibility of OTA research in food safety and toxicology. The field is highly collaborative and multidisciplinary. Oxidative stress-related terms were prominent in the keyword and thematic analyses and co-occurred with terminology related to apoptosis, DNA damage, and mitochondrial dysfunction. Thematic evolution analyses showed a transition from early studies focused on nephrotoxicity and animal models toward more recent investigations addressing molecular pathways, cellular responses, and microbiota host interactions. Comparatively less prominent or emerging bibliometric themes included the gut immune axis, co-exposure to multiple mycotoxins, and the broader representation of animal-health and productivity-related research.

conclusionsThe bibliometric and science mapping analyses indicate that the literature on OTA toxicity has evolved from predominantly organ, and animal model-related research, toward increasing attention to molecular, cellular, intestinal, and microbiota-related topics. These patterns describe changes in the conceptual structure of the literature rather than direct evidence of biological causality. Comparatively, less prominent themes, including human-relevant models, combined exposure scenarios, and microbiome-related research, may warrant further investigation.

Indexed as

BibliometricsOchratoxinsAnimalsHumansSoftwareochratoxin AOchratoxinsbibliometric analysisin vitroin vivoochratoxin A (OTA)toxicity

Identifiers

PMID42646774
PMCPMC13517462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.